| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 8e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |